The Institute for Clinical and Economic Review this fall will develop for California two annual reports : one on drug price increases it considers unsupported, the other a guide for using comparative effectiveness research to make drugs affordable. ICER announced Thursday (Mar. 3) that it received a grant from the California Health Care Foundation, a longstanding contributor to the institute’s regular comparative effectiveness research. The grant from CHCF is also expected to continue funding ICER’s independent appraisal council, the California...